Last reviewed: July 8, 2026
Last updated: July 8, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide therapy works through a progressive dosing schedule that allows your body to adapt to the medication while building toward an effective maintenance dose. Clinical trials show that gradual dose escalation over 16 weeks produces sustained weight loss averaging 15% of body weight, with many patients continuing to lose weight as their dose reaches therapeutic levels.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
Understanding Semaglutide Dosing Fundamentals
Semaglutide belongs to a medication class called GLP-1 receptor agonists, which signal your brain's appetite control centers to reduce hunger and increase fullness. The medication works by slowing stomach emptying and triggering satiety signals, making it easier to eat smaller portions without constant hunger. Dosing starts low and increases gradually because your body needs time to adjust to these powerful appetite-suppressing effects.
A typical semaglutide dosing protocol begins at 0.25 mg weekly, with increases every 4 weeks until reaching your therapeutic maintenance dose. This staggered approach allows most people to tolerate the medication well while their digestive system and appetite regulation adapt to the drug's effects. The goal is finding the lowest effective dose that produces meaningful weight loss while keeping side effects manageable.
The Four-Week Titration Schedule Explained
Week 1-4: Your starting dose of 0.25 mg weekly introduces your body to semaglutide's mechanism. During this phase, many people experience mild nausea or appetite suppression, which typically resolves within a few days as your body adjusts. Maintaining consistent hydration and eating balanced meals during this initial period helps your system acclimate to the medication.
Week 5-8: Your dose increases to 0.5 mg weekly, delivering stronger appetite suppression. Weight loss typically becomes noticeable during this phase, with many people reporting a 2-3 pound weekly reduction. If side effects occur, they're usually mild and manageable with dietary adjustments.
Week 9-12: The dose moves to 1.0 mg weekly, representing a significant increase in medication strength. This is when most people see accelerated weight loss results. Some individuals maintain at this dose long-term if they achieve their goals, while others continue to the next tier.
How Individual Metabolism Affects Semaglutide Dosing
Not everyone needs the same dose to achieve results because genetic variations influence how your body processes medication and regulates appetite. Your starting weight, metabolic rate, insulin sensitivity, and hunger hormone genetics all factor into determining your optimal therapeutic dose. Some people see significant results at 0.5 mg weekly, while others benefit from reaching higher doses.
The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) and FTO (rs9939609) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
Dose Adjustments and Long-Term Weight Loss Maintenance
Your semaglutide dose may need adjustment if you experience a weight loss plateau—a common occurrence where your body adapts and weight loss slows despite continuing the medication. Increasing your dose by one tier often restarts weight loss momentum by providing stronger appetite suppression signals. Most people find their optimal dose within the first 4-6 months of treatment.
Long-term maintenance typically involves staying at your effective dose indefinitely, as stopping semaglutide usually triggers appetite and weight rebound within weeks. PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan and remain flat-rate regardless of your dose level, so your commitment to treatment doesn't increase in cost as your dose rises. Regular check-ins with your PlexusDx provider help ensure your current dose continues delivering results while monitoring for any side effects requiring adjustment.
Managing Semaglutide Side Effects During Dose Escalation
Nausea is the most common side effect, typically occurring in the first few days after a dose increase and resolving within a week. Taking smaller, protein-rich meals and avoiding greasy or sugary foods during this adjustment window minimizes nausea significantly. Many people find that ginger tea, staying hydrated, and gentle activity like walking help manage this temporary effect.
Constipation and vomiting occur less frequently but may require dietary intervention—increasing fiber intake gradually and ensuring adequate water consumption helps prevent these issues. If side effects persist beyond two weeks or become severe, contact your PlexusDx provider immediately. Occasionally, remaining at your current dose longer before increasing, or even decreasing back to a previous dose level, allows your body to stabilize while still receiving therapeutic benefit.
Why Your Price Stays the Same as Your Dose Increases
Unlike many weight loss providers that charge per-dose or increase fees with strength levels, PlexusDx compounded semaglutide injections use a flat monthly rate at $189/mo month-to-month, or from $149/mo on the 6-month plan. This pricing structure means your dose may need to go up as your therapy progresses, but your price won't. You're never penalized financially for needing a higher dose to achieve your weight loss goals.
PlexusDx medications come from licensed 503A compounding pharmacies, ensuring quality and customization without the expensive markup of brand-name pharmaceuticals. All 50 states are served with no insurance required, no membership fees, and HSA/FSA eligibility for added affordability. This transparent, straightforward pricing removes barriers to accessing semaglutide therapy long-term.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.
Frequently Asked Questions
What is the standard starting dose of semaglutide for weight loss?
The standard starting dose is 0.25 mg injected subcutaneously once weekly. This low initial dose allows your body to adjust to the medication's appetite-suppressing effects while minimizing nausea and gastrointestinal side effects. Doses increase every 4 weeks following a structured titration schedule.
How long does it take to reach the maximum semaglutide dose?
Most people reach maximum dose after 16-20 weeks of gradual escalation, moving from 0.25 mg to 0.5 mg to 1.0 mg to 2.4 mg in 4-week intervals. However, many individuals achieve their weight loss goals at intermediate doses and don't need to reach 2.4 mg. Your PlexusDx provider tailors the timeline based on your response and tolerability.
Does PlexusDx charge more if I need to increase my semaglutide dose?
No. PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with a flat monthly rate regardless of dose level. Your dose may increase as your therapy progresses, but your price remains constant, removing financial barriers to reaching your therapeutic dose.
What happens if semaglutide side effects are unbearable at my current dose?
Contact your PlexusDx provider immediately if side effects are severe. Common solutions include staying at your current dose longer before increasing, temporarily decreasing to a previous dose level, or adjusting your diet and hydration. Most side effects resolve within a week as your body adapts, but your provider can adjust your protocol for comfort.
How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?
No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437) and FTO (rs9939609)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Ozempic vs Jardiance for Weight Loss: How They Compare
Precise Dosing for Your Journey: Understanding How to Dose Ozempic® by Clicks and Why Expert Guidance Matters